CD4 mononuclear cell infiltrates and Fas/Fas ligand positive mammary gland cells in breast tissue from a patient with Sjogren's syndrome

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1226-1231

  Attias, Moises R ^a   Kong, Liping ^b   Tortolero, Maria ^c   Maccarone, Biagio G ^e   Nakabayashi, Toru ^b   Talal, Norman ^b   Dang, Howard ^b,d  

^a Hospital de Clinicas Caracas   (Venezuela)

^b UT HSC   (United States)

^c Unidades Anat Patologica y Cirugia

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e NONE

Author keywords

Breast nodules; CD4; Exocrine glands; Fas ligand; Lymphocyte infiltrates; Sjogren's syndrome

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; PROTEIN BCL 2;

ADULT; ARTICLE; BREAST NODULE; CASE REPORT; CELL DEATH; CELL INFILTRATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATOCONJUNCTIVITIS SICCA; MAMMARY GLAND FUNCTION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SJOEGREN SYNDROME;

ANTIGENS, CD95; BREAST; BREAST DISEASES; CD4-POSITIVE T-LYMPHOCYTES; EPITHELIUM; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOCONJUNCTIVITIS SICCA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 0031857892     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Daniels TE. Salivary histopathology in diagnosis of Sjögren's syndrome. Scand J Rheumatol 1986;S61:36-43.
2. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum 1986;29:1105-11.
3. Waterhouse JP, Doniach I. Post-mortem prevalence of focal lymphocytic adenitis of the submandibular salivary glands. J Pathol Bacteriol 1966;91:53-4.
4. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965;44:187-231.
5. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's syndrome. J Clin Pathol 1968;21:656-60.
6. Greenspan JS, Daniels TE, Talal N. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg 1974;37:217-29.
7. Kincaid MC. The eye in Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren's syndrome: clinical and immunologic aspects. Berlin: Springer Verlag; 1987:25-33.
8. Trevino H, Tsiano EB, Schenker S. Gastrointestinal and hepatobilary features in Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren's syndrome: clinical and immunological aspects. Berlin: Springer Verlag; 1987:88-95.
9. Talal N. Sjögren's syndrome, lymphoproliferation and renal tubular acidosis. Ann Intern Med 1971;74:633-4.
10. Bariffi F, Pesci A, Bertorelli G, Mangenelli P, Ambanelli U. Pulmonary involvement in Sjögren's syndrome. Respiration 1984;46:82-7.
11. Schwartz IS, Strauchen JA. Lymphocytic mastopathy. An autoimmune disease of the breast? Am J Clin Pathol 1990;93:725-30.
12. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell 1991;66:233-43.
13. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression and chromosomal assignment of the Fas antigen. J Immunol 1992;148:1274-9.
14. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-9.
15. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effects of the anti-Fas antibody in mice. Nature 1993;364:806-9.
16. Richardson BC, Lalwani ND, Johnson KJ, Marks RM. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 1994;24:2640-5.
17. Mysler E, Bini P, Drappa J, et al. The apoptosis-1/fas protein in human systemic lupus erythematosus. J Clin Invest 1994;93:1029-34.
18. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-59.
19. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
20. Ashara H, Hasumuna T, Kobata T, et al. Expression of Fas and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 1996;81:27-34.
21. Kong L, Ogawa N, Nakabayashi T, et al. Fas and Fas-ligand expression in salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997;39:87-97.
22. Taylor CR, Shi S-R, Chen C, Young L, Yang C, Cote RJ. Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech Histochem 1996;71:263-70.
23. Vitali C, Bombardieri S, Moutsopoulos H, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective, concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
24. French LE, Hahne M, Viard I, et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996;133:335-43.
25. Nakajima T, Aono H, Hasunuma T, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
26. Kobayashi N, Hamamoto Y, Yamamoto N. Is TNF involved in the progression of AIDS? Virus Genes 1990;4:183-90.
27. Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection in Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatol 1994;19:1354-9.
28. Strober W, Ehrhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993;75:203-5.
29. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996;184:1513-8.
30. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
31. Mountz J, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
32. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
33. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Intnl Immunol 1994;6:1567-74.
34. Wilson SE, Li Q, Weng J, et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci 1996;37:1582-92.
35. Suzuki A, Eguchi Y, Enarí M, et al. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during estrous cycle. EMBO J 1996;15:211-5.
36. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997;275:960-3.
37. Keane MM, Ettenberg SA, Lowery GA, Russell EK, Lipkowitz S. Fas expression and function in normal and malignant breast cell lines. Cancer Res 1996;56:4791-8.
38. Suzuki A, Goto Y, Iguchi T. Progression of PDMT is accompanied by lack of Fas and intense expression of Bcl-2 and PKC-epsilon. Carcinogenesis 1997;18:883-7.
39. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996;180:152-9.
40. Cheng J, Zhou T, Liu C, et al. Protection on fas-mediated apoptosis by a soluble form of the fas molecule. Science 1994;263:1759-62.
41. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor for tumor necrosis factor. J Exp Med 1989;169:1747-56.